BG104812A - Нови дихидропиримидини - Google Patents

Нови дихидропиримидини

Info

Publication number
BG104812A
BG104812A BG104812A BG10481200A BG104812A BG 104812 A BG104812 A BG 104812A BG 104812 A BG104812 A BG 104812A BG 10481200 A BG10481200 A BG 10481200A BG 104812 A BG104812 A BG 104812A
Authority
BG
Bulgaria
Prior art keywords
compounds
dihydropyrimidines
new
new dihydropyrimidines
medicaments
Prior art date
Application number
BG104812A
Other languages
English (en)
Other versions
BG64649B1 (bg
Inventor
Joern Stoelting
Juergen Stoltefuss
Siegfried Goldmann
Thomas Kraemer
Karl-Heinz Schlemmer
Ulrich Niewoehner
Arnold Paessens
Erwin Graef
Stefan Lottmann
Karl Deres
Olaf Weber
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG104812A publication Critical patent/BG104812A/bg
Publication of BG64649B1 publication Critical patent/BG64649B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)

Abstract

Съединенията се използват за лечение и профилактика на хепатит В. Изобретението се отнася до съединения с общи формули, в които значенията на заместителите са посочени в описанието, до метод за получаване на тези съединения и до приложението им католекарствени средства.
BG104812A 1998-04-18 2000-09-29 Нови дихидропиримидини BG64649B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19817264A DE19817264A1 (de) 1998-04-18 1998-04-18 Neue Dihydropyrimidine

Publications (2)

Publication Number Publication Date
BG104812A true BG104812A (bg) 2001-06-29
BG64649B1 BG64649B1 (bg) 2005-10-31

Family

ID=7864972

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104812A BG64649B1 (bg) 1998-04-18 2000-09-29 Нови дихидропиримидини

Country Status (37)

Country Link
US (3) US6696451B1 (bg)
EP (1) EP1080086B1 (bg)
JP (2) JP4590097B2 (bg)
KR (1) KR100636771B1 (bg)
CN (1) CN1159311C (bg)
AR (1) AR018187A1 (bg)
AT (1) ATE223401T1 (bg)
AU (1) AU740318B2 (bg)
BG (1) BG64649B1 (bg)
BR (2) BR9909730B1 (bg)
CA (1) CA2328780C (bg)
CO (1) CO5021127A1 (bg)
CU (1) CU23049A3 (bg)
CZ (1) CZ293482B6 (bg)
DE (2) DE19817264A1 (bg)
DK (1) DK1080086T3 (bg)
ES (1) ES2183548T3 (bg)
GT (1) GT199900056A (bg)
HK (1) HK1039119A1 (bg)
HU (1) HUP0102372A3 (bg)
ID (1) ID27263A (bg)
IL (2) IL138584A0 (bg)
MY (1) MY126527A (bg)
NO (2) NO321985B1 (bg)
NZ (1) NZ507569A (bg)
PE (1) PE20000427A1 (bg)
PL (1) PL193898B1 (bg)
PT (1) PT1080086E (bg)
RU (1) RU2245881C9 (bg)
SI (1) SI1080086T1 (bg)
SK (1) SK286407B6 (bg)
SV (1) SV1999000047A (bg)
TR (1) TR200003011T2 (bg)
TW (1) TW548274B (bg)
UA (1) UA63998C2 (bg)
WO (1) WO1999054326A1 (bg)
ZA (1) ZA200005136B (bg)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4289100A (en) * 1999-03-25 2000-10-16 Bayer Aktiengesellschaft Dihydropyrimidines and their use in the treatment of hepatitis
AU5568400A (en) 1999-06-23 2001-01-09 Ajinomoto Co., Inc. Novel dihydropyrimidine derivatives
WO2001045712A1 (de) * 1999-12-22 2001-06-28 Bayer Aktiengesellschaft Arzneimittelkombinationen gegen virale erkrankungen
DE10012823A1 (de) * 2000-03-16 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10013125A1 (de) * 2000-03-17 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10013126A1 (de) * 2000-03-17 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10125131A1 (de) * 2001-05-23 2002-12-05 Bayer Ag Verfahren zur Spaltung des Methyl 4-(2-chlor-4-fluorphenyl)-2-(3,5-difluor-2-pyridinyl)-6-methyl-1,4-dihydro-5-pyrmidincarboxylat-Racemats
US20040092735A1 (en) * 2002-11-08 2004-05-13 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of cefuroxime sodium
CN101104617B (zh) * 2006-07-10 2010-06-23 北京摩力克科技有限公司 二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
CN101104604B (zh) 2006-07-10 2011-03-02 北京摩力克科技有限公司 光学纯二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
RU2452733C2 (ru) * 2007-04-27 2012-06-10 Пэдью Фарма Л.П. Антагонисты trpv1 и их применение
PT2514750E (pt) * 2007-06-18 2014-01-23 Sunshine Lake Pharma Co Ltd Tiazolil dihidropirimidinas substituídas com bromo-fenilo
BRPI0815562A2 (pt) 2007-07-12 2015-02-18 Novartis Ag Soluções farmacêuticas orais contendo telbivudina.
US20130267517A1 (en) 2012-03-31 2013-10-10 Hoffmann-La Roche Inc. Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
AU2013305390C1 (en) 2012-08-24 2015-12-24 Ruyuan Wei Xiang Technology Co., Ltd. Dihydropyrimidine compounds and their application in pharmaceuticals
SG11201500377UA (en) 2012-09-10 2015-02-27 Hoffmann La Roche 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
CN103664899B (zh) * 2012-09-11 2017-06-16 广东东阳光药业有限公司 杂芳基取代的二氢嘧啶类化合物及其在药物中的应用
US20150292045A1 (en) * 2012-11-09 2015-10-15 Indiana University Research And Technology Corporation Alternative uses for hbv assembly effectors
CN110960778B (zh) 2013-03-15 2022-09-30 费雪派克医疗保健有限公司 用于医疗回路的组件
BR102014028162A2 (pt) * 2013-11-12 2015-09-08 Dow Agrosciences Llc processo para fluoração de compostos
CA2920415A1 (en) 2013-11-19 2015-05-28 Sunshine Lake Pharma Co., Ltd. Dihydropyrimidine compounds and their application in pharmaceuticals
AU2014356984B2 (en) 2013-11-27 2018-01-04 Sunshine Lake Pharma Co., Ltd. Processes for preparing dihydropyrimidine derivatives and intermediates thereof
US9771358B2 (en) 2014-03-28 2017-09-26 Sunshine Lake Pharma Co., Ltd. Dihydropyrimidine compounds and their application in pharmaceuticals
CN105153164B (zh) * 2014-05-30 2018-10-30 齐鲁制药有限公司 作为hbv抑制剂的二氢嘧啶并环衍生物
EP3150600B1 (en) * 2014-05-30 2018-06-27 Qilu Pharmaceutical Co., Ltd. Dihydropyrimido loop derivative as hbv inhibitor
AU2016214799A1 (en) 2015-02-07 2017-06-15 Sunshine Lake Pharma Co., Ltd. Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticals
WO2019001420A1 (en) * 2017-06-27 2019-01-03 Janssen Pharmaceutica Nv HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING INFECTIONS WITH HEPATITIS B VIRUS
US10759774B2 (en) 2017-09-28 2020-09-01 The Curators Of The University Of Missouri Inhibitors of hepatitis B virus targeting capsid assembly
WO2019086141A1 (en) 2017-11-02 2019-05-09 Aicuris Gmbh & Co. Kg Novel, highly active amino-thiazole substituted indole-2-carboxamides active against the hepatitis b virus (hbv)
BR112020008765A2 (pt) 2017-11-02 2020-10-20 Aicuris Gmbh & Co. Kg indol-2-carboxamidas pirazolo-piperidina substituídas altamente ativas inovadoras ativas contra o vírus da hepatite b (hbv)
US20210220356A1 (en) * 2018-05-08 2021-07-22 Janssen Sciences Ireland Unlimited Company Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseases
US11053235B2 (en) 2018-08-09 2021-07-06 Janssen Sciences Ireland Unlimited Company Substituted 1,4-dihydropyrimidines for the treatment of HBV infection or HBV-induced diseases
AR116946A1 (es) 2018-11-02 2021-06-30 Aicuris Gmbh & Co Kg Derivados de urea 6,7-dihidro-4h-pirazolo[4,3-c]piridinas activas contra el virus de la hepatitis b (vhb)
SG11202104132WA (en) * 2018-11-02 2021-05-28 Aicuris Gmbh & Co Kg Novel urea 6,7-dihydro-4h-thiazolo[5,4-c]pyridines active against the hepatitis b virus (hbv)
UY38434A (es) 2018-11-02 2020-05-29 Aicuris Gmbh & Co Kg Nuevas 6,7-dihidro-4h-pirazolo[1,5-a]pirazin indol-2-carboxamidas activas contra el virus de la hepatitis b (hbv)
AR116947A1 (es) 2018-11-02 2021-06-30 Aicuris Gmbh & Co Kg Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas-indol-2-carboxamidas activas contra el virus de la hepatitis b (vhb)
UY38435A (es) 2018-11-02 2020-05-29 Aicuris Gmbh & Co Kg Nuevas urea 6,7-dihidro-4h-pirazol[1,5-a] pirazinas activas contra el virus de la hepatitis b (vhb)
UY38437A (es) 2018-11-02 2020-05-29 Aicuris Gmbh & Co Kg Nuevas urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas activas contra el virus de la hepatitis b (hbv)
US20220048919A1 (en) 2018-12-20 2022-02-17 Janssen Phrmaceutica NV Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis b infections
SG11202111198QA (en) 2019-04-30 2021-11-29 Aicuris Gmbh & Co Kg Novel indolizine-2-carboxamides active against the hepatitis b virus (hbv)
WO2020221826A1 (en) 2019-04-30 2020-11-05 Aicuris Gmbh & Co. Kg Novel indole-2-carboxamides active against the hepatitis b virus (hbv)
EP3962909B1 (en) 2019-04-30 2023-10-04 AiCuris GmbH & Co. KG Novel oxalyl piperazines active against the hepatitis b virus (hbv)
JP2022531199A (ja) 2019-04-30 2022-07-06 アイクリス ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト Ｂ型肝炎ウイルス（ｈｂｖ）に対し活性な新規のフェニル及びピリジル尿素
WO2020255016A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH550189A (de) 1971-01-08 1974-06-14 Ciba Geigy Ag Verfahren zur herstellung von neuen dibenzo (b,f) thiepincarbonsaeuren.
CH569043A5 (bg) 1973-01-23 1975-11-14 Ciba Geigy Ag
US4371537A (en) * 1981-08-13 1983-02-01 The Dow Chemical Company Sulfur-substituted phenoxypyridines having antiviral activity
DE3234684A1 (de) * 1982-09-18 1984-03-22 Bayer Ag, 5090 Leverkusen Neue dihydropyrimidine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
JPS60185764A (ja) * 1984-03-05 1985-09-21 Wako Pure Chem Ind Ltd ピリジン誘導体の新規な製造法
US4698340A (en) 1984-07-19 1987-10-06 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine derivatives, processes for preparation thereof and composition containing the same
US4727073A (en) 1984-10-01 1988-02-23 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine derivatives and composition of the same
GB8906168D0 (en) * 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
EP0941222A2 (en) * 1996-11-12 1999-09-15 Novartis AG Pyrazole derivatives useful as herbicides
SE9702564D0 (sv) * 1997-07-02 1997-07-02 Astra Ab New compounds

Also Published As

Publication number Publication date
US20040167135A1 (en) 2004-08-26
HUP0102372A2 (hu) 2001-12-28
IL138584A (en) 2006-09-05
JP2002512243A (ja) 2002-04-23
US7514565B2 (en) 2009-04-07
KR20010042788A (ko) 2001-05-25
CA2328780C (en) 2008-09-23
BRPI9917862B1 (pt) 2013-05-07
JP2010241837A (ja) 2010-10-28
PL193898B1 (pl) 2007-03-30
AU740318B2 (en) 2001-11-01
DK1080086T3 (da) 2002-12-23
AU3813399A (en) 1999-11-08
MY126527A (en) 2006-10-31
BR9909730B1 (pt) 2012-09-04
BG64649B1 (bg) 2005-10-31
NO20045259L (no) 2000-12-13
AR018187A1 (es) 2001-10-31
GT199900056A (es) 2000-10-07
CO5021127A1 (es) 2001-03-27
DE59902573D1 (en) 2002-10-10
TR200003011T2 (tr) 2001-01-22
CZ20003871A3 (cs) 2001-01-17
CN1159311C (zh) 2004-07-28
US20070117812A1 (en) 2007-05-24
ID27263A (id) 2001-03-22
ES2183548T3 (es) 2003-03-16
WO1999054326A1 (de) 1999-10-28
BRPI9917862B8 (pt) 2021-05-25
CZ293482B6 (cs) 2004-05-12
WO1999054326A8 (de) 1999-12-29
IL138584A0 (en) 2001-10-31
PL343481A1 (en) 2001-08-27
US6696451B1 (en) 2004-02-24
SV1999000047A (es) 2000-06-23
NO329020B1 (no) 2010-07-26
KR100636771B1 (ko) 2006-10-23
JP4590097B2 (ja) 2010-12-01
DE19817264A1 (de) 1999-10-21
SK286407B6 (sk) 2008-09-05
BR9909730A (pt) 2000-12-19
PE20000427A1 (es) 2000-06-25
JP5237332B2 (ja) 2013-07-17
TW548274B (en) 2003-08-21
HK1039119A1 (en) 2002-04-12
NO20005215D0 (no) 2000-10-17
PT1080086E (pt) 2002-12-31
EP1080086A1 (de) 2001-03-07
NO321985B1 (no) 2006-07-31
CN1305471A (zh) 2001-07-25
RU2245881C2 (ru) 2005-02-10
NO20005215L (no) 2000-12-13
UA63998C2 (uk) 2004-02-16
CU23049A3 (es) 2005-06-24
NZ507569A (en) 2002-04-26
EP1080086B1 (de) 2002-09-04
SI1080086T1 (en) 2003-02-28
BRPI9917862A2 (bg) 2010-12-07
SK15652000A3 (sk) 2001-04-09
HUP0102372A3 (en) 2003-01-28
RU2245881C9 (ru) 2006-02-10
ATE223401T1 (de) 2002-09-15
ZA200005136B (en) 2001-03-02
CA2328780A1 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
BG104812A (bg) Нови дихидропиримидини
IL130260A0 (en) 3-thiocarbamoylpyrazole derivatives as pesticides
BG103251A (bg) Оксадиазоли, методи за получаването им и приложението им като лекарствени средства
GEP20043163B (en) Inhibitors of Caspases, Pharmaceutical Composition on its Base and Method for its Production
BG101110A (bg) Заместени пиримидинови съединения и тяхното използване
BG104056A (bg) Триазолови съединения и използването им като допамин-d3-лиганди
BG105784A (bg) Триазоли с допамин-d3 рецепторен афинитет
DE58906377D1 (en) Difluormethylverbindungen.
GEP20074185B (en) Incclusion complexs of aryl- heterocyclic salts
PL336580A1 (en) Fine-molecular compounds useful in treating inflammatory diseases
AU7278500A (en) Fungicides
MY129973A (en) Sulphonylbenzyl-substituted pyridones.
BG101194A (bg) Нови хетероарилови оксазолидинони
BG102999A (bg) Нови 2,3 дизаместени-4(3н)-хиназолинони
BG103310A (bg) Бензонафтиридини като бронхиални лечебни средства
BG103399A (bg) Нови заместени с хетероцикъл бензамиди и тяхното използване за лечение на болести
BG103219A (bg) Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие
PL289487A1 (en) Method of producing new aminophenol derivatives
IL143105A0 (en) Fused polycyclic heterocyclic compounds and pharmaceutical compositions containing the same
GEP20012416B (en) Benzopyran Derivatives Having Leukotriene-Antagonistic Action
ZA961364B (en) 1-Aryl-2-acylamino-ethane compounds
MY132550A (en) Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists
BG104232A (bg) Заместени 1,2,3,4,5,6-хексахидро-2,6-метано-3-бензазоцин- 10-оли, метод за тяхното получаване и приложението им като лекарствени средства
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
BG104910A (bg) Нови 1,2,5-тризаместени 1,2-дихидро-индазол-3-онис антиасматично, антиалергично, противовъзпалително, имуномодулиращо и нервозащитно действие, методза тяхното получаване и тяхната употреба като лекарствени средства